The outcome of the abstract submission is available via https://abstracts.emuc.org/abstracts Poster Instructions The EMUC Congress Office has chosen to offer the innovative web-based platform, PosterSessionOnline, to organise printing of posters for this year’s event. This service receives, prints and then delivers your poster to the congress venue, thus guaranteeing all posters arrive in perfect condition. More information can be found here. We kindly thank the following experts for their time and expertise during the expert poster walks: Daniele Amparone Abstract submission and late-breaking abstract submission is now closed. Abstract submission rules Topics Publication The accepted abstracts of EMUC22 are going to be published online in the EMUC resource centre, in the EMUC/ESUI app and as an online supplement by Elsevier on European Urology Open Science. If you do not want your case report(s) or video(s) published online please send an e-mail to emuc@congressconsultants.com. Please note: Copyright of the abstract(s) is assigned to the EMUC office and any conflicts with any other scientific association will be the sole responsibility of the author(s). The congress has taken place. Visit the EMUC22 Resource Centre to explore the scientific contentAbstract submission outcome
Download the poster instruction here.
Acknowledgements
Roderick Van den Bergh
Riccardo Campi
Miranda Christianen
David D Àndrea
David Lauffer
Ekatherina Laukhtina
Martina Maggi
Laura Meertens
Christoph Oing
Benjamin Pradere
Pawel Rajwa
Eduard Roussel
Abstract submission
Download the abstract submission rules here
DEADLINES
Late-breaking abstract submission deadline
1 October 2022, 23:59 hrs CEST
Abstract session types
Oral presentations and posters
Prostate Cancer, Localised – Basic Research & Trials
Prostate Cancer, Localised – Diagnosis
Prostate Cancer, Localised – Diagnosis, Pathology & Biopsies
Prostate Cancer, Localised – Treatment
Prostate Cancer, Localised – Follow up
Prostate Cancer, Localised – Follow up, Clinical / Prognosis
Prostate Cancer, Localised – Follow up, Quality of life / Patient reported outcomes
Prostate Cancer, Locally advanced – Basic Research & Trials
Prostate Cancer, Locally advanced – Diagnosis
Prostate Cancer, Locally advanced – Diagnosis, Pathology & Biopsies
Prostate Cancer, Locally advanced – Treatment
Prostate Cancer, Locally advanced – Follow up
Prostate Cancer, Locally advanced – Follow up, Clinical / Prognosis
Prostate Cancer, Locally advanced – Follow up, Quality of life / Patient reported outcomes
Prostate Cancer, Metastatic – Basic Research & Trials
Prostate Cancer, Metastatic – Diagnosis
Prostate Cancer, Metastatic – Diagnosis, Pathology & Biopsies
Prostate Cancer, Metastatic – Treatment
Prostate Cancer, Metastatic – Follow up
Prostate Cancer, Metastatic – Follow up, Clinical / Prognosis
Prostate Cancer, Metastatic – Follow up, Quality of life / Patient reported outcomes
Renal Tumour – Basic Research & Trials
Renal Tumour – Diagnosis
Renal Tumour – Treatment
Renal Tumour – Follow up, Clinical / Prognosis
Renal Tumour – Follow up
Renal Tumour – Follow up, Quality of life / Patient reported outcomes
Renal Tumour – Diagnosis, Pathology & Biopsies
Urothelial Cancer – Basic Research & Trials
Urothelial Cancer – Diagnosis
Urothelial Cancer – Diagnosis, Pathology & Biopsies
Urothelial Cancer – Treatment
Urothelial Cancer – Follow up
Urothelial Cancer – Follow up, Clinical / Prognosis
Urothelial Cancer – Follow up, Quality of life / Patient reported outcomes
Testicular Cancer – Diagnosis
Testicular Cancer – Treatment
Testicular Cancer – Follow up, Clinical / Prognosis
Testicular Cancer – Diagnosis, Pathology & Biopsies
Penile Cancer – Basic Research & Trials
Penile Cancer – Diagnosis
Penile Cancer – Diagnosis, Pathology & Biopsies
Penile Cancer – Treatment
Penile Cancer – Follow up
Penile Cancer – Follow up, Clinical / Prognosis
Penile Cancer – Follow up, Quality of life / Patient reported outcomes
Non-Disease specific